Showing results (171-180 of 182) with videos related to
Sort By:
Pageof 19
Nature|October 6, 2016
The epichaperome is an integrated chaperome network that facilitates tumour survivalAnna Rodina, Tai Wang, Pengrong Yan, et al.Journal of the National Comprehensive Cancer Network : JNCCN|February 22, 2019
NCCN Guidelines Insights: Breast Cancer, Version 3.2018Matthew P Goetz, William J Gradishar, Benjamin O Anderson, et al.Journal of the National Comprehensive Cancer Network : JNCCN|April 8, 2020
Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in OncologyWilliam J Gradishar, Benjamin O Anderson, Jame Abraham, et al.Journal of the National Comprehensive Cancer Network : JNCCN|November 10, 2025
NCCN Guidelines® Insights: Breast Cancer, Version 5.2025William J Gradishar, Meena S Moran, Jame Abraham, et al.Journal of the National Comprehensive Cancer Network : JNCCN|July 17, 2024
Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in OncologyWilliam J Gradishar, Meena S Moran, Jame Abraham, et al.Journal of the National Comprehensive Cancer Network : JNCCN|June 17, 2022
Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in OncologyWilliam J Gradishar, Meena S Moran, Jame Abraham, et al.Journal of the National Comprehensive Cancer Network : JNCCN|July 9, 2026
Breast Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In OncologyWilliam J Gradishar, Meena S Moran, Jame Abraham, et al.Journal of the National Comprehensive Cancer Network : JNCCN|November 18, 2021
NCCN Guidelines® Insights: Breast Cancer, Version 4.2021William J Gradishar, Meena S Moran, Jame Abraham, et al.Journal of the National Comprehensive Cancer Network : JNCCN|June 12, 2023
NCCN Guidelines® Insights: Breast Cancer, Version 4.2023William J Gradishar, Meena S Moran, Jame Abraham, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2021
Adjuvant Trastuzumab Emtansine Versus Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT): A Randomized Clinical TrialSara M Tolaney, Nabihah Tayob, Chau Dang, et al.Pageof 19